Terms: = Brain cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Treatment
421 results:
1. Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.
Yeung N; Li T; Lin HM; Timmins HC; Goldstein D; Harrison M; Friedlander M; Mahon KL; Giles C; Meikle PJ; Park SB; Horvath LG
JCO Precis Oncol; 2024 Apr; 8():e2300690. PubMed ID: 38691814
[TBL] [Abstract] [Full Text] [Related]
2. [Expression of immune checkpoints PD-L1, ctla4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal cancer: A Preliminary Report of Case Series.
Pan T; Yang H; Wang WY; Rui YY; Deng ZJ; Chen YC; Liu C; Hu H
Clin Colorectal Cancer; 2024 Mar; 23(1):104-110. PubMed ID: 38336555
[TBL] [Abstract] [Full Text] [Related]
4. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
5. Macro CD5L
Lu JC; Wu LL; Sun YN; Huang XY; Gao C; Guo XJ; Zeng HY; Qu XD; Chen Y; Wu D; Pei YZ; Meng XL; Zheng YM; Liang C; Zhang PF; Cai JB; Ding ZB; Yang GH; Ren N; Huang C; Wang XY; Gao Q; Sun QM; Shi YH; Qiu SJ; Ke AW; Shi GM; Zhou J; Sun YD; Fan J
Nat Commun; 2024 Jan; 15(1):621. PubMed ID: 38245530
[TBL] [Abstract] [Full Text] [Related]
6. An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer.
Mahadevia H; Uson Junior PLS; Wang J; Borad M; Babiker H
Expert Opin Pharmacother; 2024; 25(1):79-90. PubMed ID: 38193476
[TBL] [Abstract] [Full Text] [Related]
7. Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients.
Ko B; Tao K; Brennan L; Rakhade S; Chan CX; Moone JY; Zhu R; Sher A; Wang S; Bracero Y; Fullerton B; McLellan B; Geskin LJ; Saenger YM
Melanoma Res; 2024 Apr; 34(2):134-141. PubMed ID: 38181115
[TBL] [Abstract] [Full Text] [Related]
8. Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammation.
Bjursten S; Zhao Z; Al Remawi H; Studahl M; Pandita A; Simrén J; Zetterberg H; Lundell AC; Rudin A; Ny L; Levin M
EBioMedicine; 2024 Feb; 100():104955. PubMed ID: 38171113
[TBL] [Abstract] [Full Text] [Related]
9. Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT).
Gridelli C; Peters S; Mok T; Garassino M; Paz-Ares L; Attili I; de Marinis F
Lung Cancer; 2024 Jan; 187():107441. PubMed ID: 38141488
[TBL] [Abstract] [Full Text] [Related]
10. Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
Galligan A; Iravani A; Lasocki A; Wallace R; Weppler AM; Sachithanandan N; Chiang C; Colman PG; Wentworth J; Spain L; Au-Yeung G; Lee B; Kay TWH; Hicks RJ; Sandhu S; Krishnamurthy B
Front Endocrinol (Lausanne); 2023; 14():1295865. PubMed ID: 38093958
[TBL] [Abstract] [Full Text] [Related]
11. Radiogenomic landscape: Assessment of specific phagocytosis regulators in lower-grade gliomas.
Maimaiti A; Abulaiti A; Tang B; Dilixiati Y; Li X; Yakufu S; Wang Y; Jiang L; Shao H
Exp Biol Med (Maywood); 2023 Dec; 248(23):2289-2303. PubMed ID: 38062999
[TBL] [Abstract] [Full Text] [Related]
12. The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.
Hepner A; Versluis JM; Wallace R; Allayous C; Brown LJ; Trojaniello C; Gerard CL; Jansen YJ; Bhave P; Neyns B; Haydon A; Michielin O; Mangana J; Klein O; Shoushtari AN; Warner AB; Ascierto PA; McQuade JL; Carlino MS; Zimmer L; Lebbe C; Johnson DB; Sandhu S; Atkinson V; Blank CU; Lo SN; Long GV; Menzies AM
Eur J Cancer; 2024 Jan; 196():113441. PubMed ID: 37988842
[TBL] [Abstract] [Full Text] [Related]
13. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract] [Full Text] [Related]
14. Endothelial and tumor-intrinsic mechanisms of hepatic melanoma metastasis.
Wohlfeil SA; Géraud C
J Dtsch Dermatol Ges; 2024 Jan; 22(1):18-21. PubMed ID: 37884458
[TBL] [Abstract] [Full Text] [Related]
15. Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic.
Rios-Hoyo A; Arriola E
Front Immunol; 2023; 14():1221097. PubMed ID: 37876939
[TBL] [Abstract] [Full Text] [Related]
16. Bilateral inferior petrosal sinus sampling: validity, diagnostic accuracy in lateralization of pituitary microadenoma, and treatment in eleven patients with Cushing's syndrome - a single-center retrospective cohort study.
Ardakani MT; Rabizadeh S; Yadegar A; Mohammadi F; Reyhan SK; Qahremani R; Ghanaati H; Esteghamati A; Nakhjavani M
BMC Endocr Disord; 2023 Oct; 23(1):232. PubMed ID: 37872539
[TBL] [Abstract] [Full Text] [Related]
17. Society for Immunotherapy of cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.
Pavlick AC; Ariyan CE; Buchbinder EI; Davar D; Gibney GT; Hamid O; Hieken TJ; Izar B; Johnson DB; Kulkarni RP; Luke JJ; Mitchell TC; Mooradian MJ; Rubin KM; Salama AK; Shirai K; Taube JM; Tawbi HA; Tolley JK; Valdueza C; Weiss SA; Wong MK; Sullivan RJ
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37852736
[TBL] [Abstract] [Full Text] [Related]
18. Intensity-modulated radiotherapy for cushing's disease: single-center experience in 70 patients.
Lian X; Xu Z; Sun S; Wang W; Zhu H; Lu L; Hou X; Zhang F
Front Endocrinol (Lausanne); 2023; 14():1241669. PubMed ID: 37822603
[TBL] [Abstract] [Full Text] [Related]
19. Clinical features, diagnosis and treatment outcomes of Cushing's disease in children: A multicenter study.
Tarçın G; Çatlı G; Çetinkaya S; Eren E; Kardelen AD; Akıncı A; Böber E; Kara C; Yıldırım R; Er E; Polat R; Özhan B; Yıldız M; Kor Y; Evliyaoğlu O; Dündar B; Ercan O
Clin Endocrinol (Oxf); 2024 Jan; 100(1):19-28. PubMed ID: 37814958
[TBL] [Abstract] [Full Text] [Related]
20. Does subtotal resection ameliorate hypothalamic morbidity in pediatric craniopharyngioma? A 30-year retrospective cohort study.
Yousuf OK; Salehani A; Zimmerman K; Estevez-Ordonez D; Madura C; Arynchyna-Smith A; Johnston JM; Rozzelle CJ; Rocque BG; Blount JP
J Neurosurg Pediatr; 2023 Nov; 32(5):569-575. PubMed ID: 37728405
[TBL] [Abstract] [Full Text] [Related]
[Next]
